-->

Company Registry

Factor Bioscience Inc
Profile last edited on: 6/12/2020

genetic and epigenetic engineering of cells
Year Founded
2011
First SBIR Year
2012
Latest SBIR Award
2012
Program Status
Inactive

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

100 Morrissey Boulevard 3rd Floor
Boston, MA 02125
   (781) 640-1031
   info@factorbio.com
   www.factorbio.com
Multiple Locations:   
Congressional District:   07
County:   Suffolk

Public Profile

With an emphasis on regenerative medicine Factor Bioscience is developing personalized cell-based therapeutics from patient cells. Involving a team with years of experience in DNA-free gene expression and cellular reprogramming, Factor is focused on the development of the first autologous cell-replacement therapies for a range of degenerative diseases. Of particular current focusare efforts to accelerate the development of new treatments for Alzheimer’s Disease

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
N/A
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
---
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Matt Angell -- Co-Founder, Chairman and CEO

  Christopher Rohde --

  T Mark Scott --

SBIR firms in the news

There are no news available.